Imidazopyridine derivatives having an affinity for melanocortin receptors

Details for Australian Patent Application No. 2004228416 (hide)

International Classifications

Event Publications

3 November 2005 PCT application entered the National Phase

PCT publication WO2004/089951 Priority application(s): WO2004/089951

2 March 2006 Amendment Made

The nature of the amendment is: Amend the invention title to read Imidazopyridine derivatives as melanocortin receptor agonists or antagonists

19 March 2009 Alteration of Name

The name of the applicant has been altered to IPSEN Pharma S.A.S

11 February 2010 Application Accepted

Published as AU-B-2004228416

4 March 2010 Corrigenda

Applications Accepted - Name Index Under the name IPSEN Pharma S.A.S., Application No. 2004228416, under INID (54) correct the title to read Imidazopyridine derivatives as melanocortin receptor agonists or antagonists

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.